BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4440864)

  • 1. Thin layer chromatographic and colorimetric methods for monitoring the purity of S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR-2721).
    Washburn LC; Hayes RL
    Anal Chem; 1974 Dec; 46(14):2231-2. PubMed ID: 4440864
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721) on intestinal crypt survival. I. 4 MeV x-rays.
    Sigdestad CP; Connor AM; Scott RM
    Radiat Res; 1975 May; 62(2):267-75. PubMed ID: 1124278
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR 2721) on intestinal crypt survival. II. Fission neutrons.
    Sigdestad CP; Connor AM; Scott RM
    Radiat Res; 1976 Mar; 65(3):430-9. PubMed ID: 1265205
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioprotective and toxic effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721) on the development of immunocompetent cells.
    Yuhas JM
    Cell Immunol; 1972 Jul; 4(3):256-63. PubMed ID: 5064475
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological factors affecting the radioprotective efficiency of S-2-[3-aminopropylamino]ethylphosphorothioic acid (WR-2721): LD 50(7) doses.
    Yuhas JM
    Radiat Res; 1971 Aug; 47(2):526-9. PubMed ID: 5561940
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiotherapy of experimental lung tumors in the presence and absence of a radioprotective drug, S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
    Yuhas JM
    J Natl Cancer Inst; 1973 Jan; 50(1):69-78. PubMed ID: 4692869
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioprotection of mouse testis by S-2-(3-aminopropylamino)ethylphosphorothioic acid.
    Bhartiya J; Bhartiya HC
    Radiobiol Radiother (Berl); 1985; 26(3):389-93. PubMed ID: 2997832
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids.
    Anderson KW; Krohn KA; Grunbaum Z; Phillips RB; Mahler PA; Menard TW; Spence AM; Rasey JS
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1511-5. PubMed ID: 6090353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of WR-2721 against radiation-induced injury of murine gut, testis, lung, and lung tumor nodules.
    Milas L; Hunter N; Reid BO
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):535-8. PubMed ID: 6286549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in normal tissue responsiveness to WR-2721.
    Yuhas JM; Afzal SM; Afzal V
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1537-9. PubMed ID: 6090357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Milas L; Hunter N; Stephens LC; Peters LJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical studies with WR-2721.
    Kligerman MM; Shaw MT; Slavik M; Yuhas JM
    Cancer Clin Trials; 1980; 3(3):217-21. PubMed ID: 6254682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral toxicity and efficacy of WR-2721 as a radioprotectant.
    Bogo V; Jacobs AJ; Weiss JF
    Radiat Res; 1985 Nov; 104(2 Pt 1):182-90. PubMed ID: 3001816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of Valexon by a thin-layer chromatographic method].
    Krasnykh AA; Shvets DA
    Gig Sanit; 1979 Dec; (12):50-1. PubMed ID: 520846
    [No Abstract]   [Full Text] [Related]  

  • 17. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Yuhas JM
    Cancer Res; 1980 May; 40(5):1519-24. PubMed ID: 6245795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effects of WR-2721 on mouse testicular cells.
    Meistrich ML; Finch MV; Hunter N; Milas L
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1551-4. PubMed ID: 6090360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thin layer chromatographic-gravimetric determination of O,O-diethyl S-(N-isopropylcarbamoylmethyl) phosphorothiolothionate (prothoate) in technical products and liquid formulations.
    Bazzi B; Fabbrini R; Radice M
    J Assoc Off Anal Chem; 1971 Nov; 54(6):1313-5. PubMed ID: 5151698
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticlastogenic effect of S-2-(3-aminopropylamino) ethylphosphorothioic acid against X-rays in mice.
    Mazur L
    Physiol Res; 1996; 45(1):59-63. PubMed ID: 8884925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.